Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study
Top Cited Papers
Open Access
- 3 December 2020
- Vol. 76 (4), 405-407
- https://doi.org/10.1136/thoraxjnl-2020-216377
Abstract
This study assessed symptoms and their determinants 1.5–6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5–6 months than during COVID-19; median (IQR) 0 (0–2) versus 8 (6–11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.Keywords
This publication has 8 references indexed in Scilit:
- Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?ERJ Open Research, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluationJournal of Medical Virology, 2020
- Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome SurvivorsArchives of Internal Medicine, 2009
- Measuring symptomatic and functional recovery in patients with community-acquired pneumoniaJournal of General Internal Medicine, 1997
- Can Comorbidity Be Measured By Questionnaire Rather than Medical Record Review?Medical Care, 1996